6th Joint Call of JPIAMR

Basic Information

Control of AMR needs actions addressing issues at human, animal and environmental levels, according to an approach usually referred to as “One Health”. Following publication of the WHO Global priority list of antibiotic-resistant bacteria (including Mycobacterium tuberculosis multi-and extensively drug resistant)[1], the JPIAMR is launching a joint transnational call with the aim to discover new targets, compounds and tools with the potential to help controlling diseases caused by resistant bacteria from the above-mentioned WHO pathogen list in human, animal or environmental settings.

Network	JPI AMR
Website	https://www.jpiamr.eu/6thcall/
Aim of the joint call	Control of AMR needs actions addressing issues at human, animal and environmental levels, according to an approach usually referred to as “One Health”. Following publication of the WHO Global priority list of antibiotic-resistant bacteria (including Mycobacterium tuberculosis multi-and extensively drug resistant)[1], the JPIAMR is launching a joint transnational call with the aim to discover new targets, compounds and tools with the potential to help controlling diseases caused by resistant bacteria from the above-mentioned WHO pathogen list in human, animal or environmental settings.
Type of joint call	Two Stages - Call with pre-proposals and full proposals submissions
Events	Launch date 03/01/2018 Deadline Pre-Proposal 07/03/2018 Submitted proposal: n/a Deadline Full-Proposal 14/06/2018 Submitted proposal: n/a Evaluation End Date 01/11/2018 Successful proposal: n/a Proposals funded: 10
Is call co-funded?	No
Call follow up funding	n/a
Call reasons	n/a
Research fields	Health
Type of research	n/a
Target groups	n/a
Participating networks	n/a

Organisations Participating

Country	Organisation
Belgium	National Fund for Scientific Research (FNRS)
Belgium	Research Foundation Flanders (FWO)
Czech Republic	Ministry of Education Youth and Sports (MEYS-MSMT)
Egypt	Academy of Scientific Research and Technology (ASRT)
Finland	Academy of Finland (AKA)
France	National Research Agency (ANR)
Germany	Federal Ministry of Education and Research (BMBF)
Ireland	Health Research Board (HRB)
Israel	Medical Research Administration Chief Scientist Office Israeli Ministriy of Health (CSO-MOH)
Italy	Ministry of Health (MOH/MDS)
Latvia	State Education Development Agency (VIAA)
Norway	Research Council of Norway (RCN)
Poland	National Science Centre (NCN)
Romania	Ministry of Education, Research and Innovation (MERI)
Spain	Institute of Health Carlos III (ISCIII)
Spain	Ministry of Economy and Competitiveness (MINECO)
Sweden	Swedish Research Council (VR/SRC)
Switzerland	Swiss National Science Foundation (SNSF/SNF)

Funded Projects

Acronym	Title	Start	End	No. partners
ANTIBIO-LAB	Anti-biofilm therapies using local application of bacterioph...	01/01/2019	31/12/2021	6
Anti-Persistence	Fighting antibiotic-resistant superbugs with anti-persister ...	01/01/2019	31/12/2021	4
CRISPRattacK	Advancing CRISPR antimicrobials to combat the bacterial path...	01/01/2019	31/12/2021	5
DISRUPT	Fighting antimicrobial resistant infections by high-throughp...	01/01/2019	31/12/2021	4
Explore	Exploration of the TPP riboswitch as a new target for antibi...	01/01/2019	31/12/2021	5
FLAV4AMR	Flavodoxin inhibitors to kill resistant bacteria	01/01/2019	31/12/2021	4
MTI4MDR-TB	Development of novel Mycobacterial Tolerance Inhibitors (MTI...	01/01/2019	31/12/2021	5
RESET-ME	Restoring E. coli Sensitivity for Antibiotics by blocking To...	01/01/2019	31/12/2021	5
RIBOTARGET	Development of novel ribosome-targeting antibiotics	01/01/2019	31/12/2021	7
SCAN	Design, synthesis and lead generation of novel siderophore c...	01/01/2019	31/12/2021	3